March 6, 2013
FDA panel sees risk in long-used osteoporosis drug
By Logan Lafferty
A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer…”We have a whole lot of patients who can’t take the other drugs, and I think our patients would be in […]
View full entry
Tags: bone strength, Dr. Bart Clark, federal health, MPR, osteoperosis, risk increase